UNDERWRITER’S WARRANT AGREEMENTUnderwriter’s Warrant Agreement • February 14th, 2008 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 14th, 2008 Company Industry JurisdictionUnderwriter’s Warrant Agreement (the “Agreement”), dated as of February 19, 2008, between Opexa Therapeutics, Inc. (the “Company”) and ______________ (the “Holder”).
FORM OF UNDERWRITER’S WARRANT AGREEMENTUnderwriter’s Warrant Agreement • December 20th, 2007 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 20th, 2007 Company Industry JurisdictionWHEREAS, the Company and MDB Capital Group LLC and certain other persons (collectively, the “Underwriters”) have entered into an underwriting agreement dated ____ __, 2008 (the “Underwriting Agreement”) whereby the Company has agreed to issue and sell to Underwriters an aggregate of [4,500,000] shares of common stock of the Company (the “Firm Shares” or in the singular a “Firm Share”) and an aggregate of [4,500,000] Series E warrants (The “Firm Warrants” or in the singular a “Firm Warrant”);